Skip to main content
Caplight Logo









BEIT

BEIT

Private
KrakówHealthcare & Life Scienceshttps://beit.tech/

Last Round

Seed

Oct 1, 2019

Total Funding Raised

$1.4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

BEIT is a deep-tech company that develops a hybrid classical-quantum computational chemistry platform to improve the accuracy and scalability of molecular modeling for drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Quantum Computing, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

computational chemistrydrug discoverymolecular modelingquantum-inspired algorithmsin silico drug discoverymolecular dockinghigh-performance computingHPCfree energy calculationcovalent inhibitorphysics-based simulationcomputational biologyGPU-acceleratedAI-driven drug discoverybiotech software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BEIT Comparables

Compare BEIT with similar companies based on industry and business-model similarity.

BEIT comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kvantify
87%
QSimulate
85%
Qubit Pharmaceuticals
81%

BEIT Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 1, 2019

Key People

Founding team and executive leadership

Paulina Mazurek

CEO

Executive Team

Tom Ginsberg

Chief Technology Officer

Executive Team

Konrad Pawlus

Chief Product Officer

Executive Team

BEIT Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 205% MoM, reaching 3.7K.

  • Mar 6, 2026

    Monthly visitors grew 69% MoM, reaching 6.4K.

BEIT Filings

Explore SEC and related filing metadata, where available.

BEIT filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BEIT's valuation, stock price, and market status.

Is BEIT a public or private company?

BEIT is a private company.

What is the current stock price of BEIT?

BEIT is a private company with no public stock price. Caplight tracks BEIT's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is BEIT worth (valuation)?

Valuation information for BEIT is not publicly available.

Can I buy BEIT stock?

BEIT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BEIT's last funding round?

BEIT's most recent funding round was Seed on October 1, 2019.

Who are the main investors in BEIT?

Key investors in BEIT include Kindred Capital, Tensor Ventures.

Will BEIT IPO soon?

No public IPO plans have been announced for BEIT.

How can I track BEIT secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BEIT's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKraków
Employee Range19
Year Founded2016
Last FundingOct 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?